Velocity’s research site in Metairie was founded in 2012 as MedPharmics, and acquired by Velocity in 2022. Since its inception, the site has built a reputation of success conducting trials in Infectious Diseases and Women’s Health, and has completed 50+ vaccine trials. Additionally, our Metairie team is actively expanding to new therapeutic areas to better serve the diverse population of the greater New Orleans area.
The site is conveniently located close to Veteran’s Highway and Clearview Parkway, and is positioned around the corner from a local hospital. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Metairie team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.